0
0
42 words
0
Comments
After some deals and drug launches disappointed, Vas Narasimhan heard from investors—and hired an outspoken Wall Street analyst to manage strategy
You are the first to view
https://www.wsj.com/health/pharma/how-novartiss-ceo-learned-from-his-mistakes-and-got-help-from-an-unlikely-quarter-b087ebbb
Create an account or login to join the discussion